Prescription Opioid Epidemic and Infant Outcomes
Top Cited Papers
Open Access
- 1 May 2015
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 135 (5), 842-850
- https://doi.org/10.1542/peds.2014-3299
Abstract
BACKGROUND AND OBJECTIVES: Although opioid pain relievers are commonly prescribed in pregnancy, their association with neonatal outcomes is poorly described. Our objectives were to identify neonatal complications associated with antenatal opioid pain reliever exposure and to establish predictors of neonatal abstinence syndrome (NAS). METHODS: We used prescription and administrative data linked to vital statistics for mothers and infants enrolled in the Tennessee Medicaid program between 2009 and 2011. A random sample of NAS cases was validated by medical record review. The association of antenatal exposures with NAS was evaluated by using multivariable logistic regression, controlling for maternal and infant characteristics. RESULTS: Of 112 029 pregnant women, 31 354 (28%) filled ≥1 opioid prescription. Women prescribed opioid pain relievers were more likely than those not prescribed opioids (P < .001) to have depression (5.3% vs 2.7%), anxiety disorder (4.3% vs 1.6%) and to smoke tobacco (41.8% vs 25.8%). Infants with NAS and opioid-exposed infants were more likely than unexposed infants to be born at a low birth weight (21.2% vs 11.8% vs 9.9%; P < .001). In a multivariable model, higher cumulative opioid exposure for short-acting preparations (P < .001), opioid type (P < .001), number of daily cigarettes smoked (P < .001), and selective serotonin reuptake inhibitor use (odds ratio: 2.08 [95% confidence interval: 1.67–2.60]) were associated with greater risk of developing NAS. CONCLUSIONS: Prescription opioid use in pregnancy is common and strongly associated with neonatal complications. Antenatal cumulative prescription opioid exposure, opioid type, tobacco use, and selective serotonin reuptake inhibitor use increase the risk of NAS.Keywords
This publication has 33 references indexed in Scilit:
- Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?jpme, 2013
- Prevalence of Substance Use and Psychiatric Disorders in a Highly Select Chronic Pain PopulationJournal of Addiction Medicine, 2013
- Committee Opinion No. 524Obstetrics & Gynecology, 2012
- Methadone dose and neonatal abstinence syndrome—systematic review and meta‐analysisAddiction, 2010
- Ongoing Pain Despite Aggressive Opioid Pain Management Among Persons With HIVThe Clinical Journal of Pain, 2010
- The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity SurveyDepression and Anxiety, 2005
- Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposureDrug and Alcohol Dependence, 2004
- Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosisObstetrics & Gynecology, 2002
- Neonatal opiate abstinence syndrome in term and preterm infantsThe Journal of Pediatrics, 1991
- Risk of Sudden Infant Death Syndrome after Immunization with the Diphtheria–Tetanus–Pertussis VaccineThe New England Journal of Medicine, 1988